$0.45 -0.02 (%) Orexigen Therapeutics Inc - NASDAQ

Apr. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Seth Klarman's Largest New Buys and Adds

    GuruFocus | Feb. 15, 2016 | 16:25PM EST
  2. Benzinga's Top Initiations

    Benzinga | Dec. 11, 2015 | 09:58AM EST
  3. Zafgen Plunges On Death In Obesity-Drug Trial

    IBD | Dec. 2, 2015 | 15:20PM EST
  4. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 16, 2015 | 08:13AM EST
  6. Seth Klarman Buys Pharmaceutical Company's Shares to Fund International Drug Launch

    GuruFocus | Oct. 12, 2015 | 17:36PM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 12, 2015 | 08:15AM EST
  8. Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss Estimates

    Benzinga | Sep. 16, 2015 | 10:25AM EST
  9. Mid-Morning Market Update: Markets Mostly Flat; Krispy Kreme Misses Q2 Estimates

    Benzinga | Sep. 10, 2015 | 10:14AM EST
  10. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 6, 2015 | 08:12AM EST
  11. Orexigen Announces Korean Distributorship Agreement with Kwang Dong Pharmaceutical Company

    Benzinga | Aug. 6, 2015 | 06:59AM EST
  12. Actavis faces suit over diet pill

    IBD | Jun. 5, 2015 | 18:47PM EST
  13. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 21:22PM EST
  14. Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study

    Benzinga | Mar. 3, 2015 | 21:07PM EST
  15. Contrave may help heart

    IBD | Mar. 3, 2015 | 18:29PM EST
  16. Orexigen Soars On Obesity Drug's Surprise Health Boon

    IBD | Mar. 3, 2015 | 13:54PM EST
  17. UPDATE: Orexigen Therapeutics Shares Drop After Q4 Results

    Benzinga | Feb. 25, 2015 | 09:36AM EST
  18. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  19. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  21. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  22. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  23. Friday's Big Gainers With High Short Interest

    Benzinga | Dec. 19, 2014 | 11:41AM EST
  24. How To Profit From The Obesity Epidemic

    Benzinga | Dec. 8, 2014 | 16:54PM EST
  25. These 4 Biotech Stocks Have Been On Fire

    Benzinga | Dec. 8, 2014 | 15:31PM EST
  26. 2 Skyrocketing Biotech Stocks In A Stalling Market

    Benzinga | Nov. 17, 2014 | 11:33AM EST
  27. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  28. Mid-Afternoon Market Update: Sothebys Climbs On Upbeat Revenue; GoPro Shares Dip

    Benzinga | Nov. 10, 2014 | 15:13PM EST
  29. Mid-Day Market Update: Gogo Shares Slide On Wider Loss; Achillion Pharmaceuticals Shares Jump

    Benzinga | Nov. 10, 2014 | 13:05PM EST
  30. Morning Market Movers

    Benzinga | Nov. 10, 2014 | 09:43AM EST
  31. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  32. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 7, 2014 | 10:11AM EST
  33. Takeda And Orexigen Announce FDA Approval of Contrave Extended-release Tablets For Chronic Weight Management

    Benzinga | Sep. 11, 2014 | 07:01AM EST
  34. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 30, 2014 | 08:13AM EST
  35. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  36. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  37. Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%

    Benzinga | Jun. 11, 2014 | 15:48PM EST
  38. Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen Shares Slide

    Benzinga | Jun. 11, 2014 | 12:34PM EST
  39. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  40. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  41. Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit

    Benzinga | Jun. 11, 2014 | 10:13AM EST
  42. Morning Market Losers

    Benzinga | Jun. 11, 2014 | 09:46AM EST
  43. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 11, 2014 | 08:09AM EST
  44. US Stock Futures Tumble; World Bank Lowers Global Growth Outlook

    Benzinga | Jun. 11, 2014 | 07:31AM EST
  45. Earnings Scheduled For March 12, 2014

    Benzinga | Mar. 12, 2014 | 05:09AM EST
  46. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 2, 2013 | 08:43AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 26, 2013 | 08:10AM EST
  48. Mid-Afternoon Market Update: Markets Turn Back as Momentum Stocks Drop

    Benzinga | Nov. 25, 2013 | 15:48PM EST
  49. Mid-Day Market Update: SeaDrill Drops On Downbeat Earnings; Giant Interactive Shares Spike Higher

    Benzinga | Nov. 25, 2013 | 13:04PM EST
  50. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 25, 2013 | 08:12AM EST
Trading Center